<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04565977</url>
  </required_header>
  <id_info>
    <org_study_id>042.PHA.2020.A</org_study_id>
    <nct_id>NCT04565977</nct_id>
  </id_info>
  <brief_title>Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States</brief_title>
  <official_title>Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Methodist Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective, cohort study chart review in patients with hypercoagulable states.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Retrospective, cohort study chart review in patients at Methodist Health System&#xD;
&#xD;
        -  Data will be pulled on all patients with hypercoagulable states identified by&#xD;
           ICD-9/ICD-10 codes from January 1st, 2015 to December 31st, 2019&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">June 10, 2021</completion_date>
  <primary_completion_date type="Actual">June 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of thrombotic events during the study period</measure>
    <time_frame>Jan 1,2015 - Dec 31st, 2019</time_frame>
    <description>Rates of thrombotic events during the study period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rates of hemorrhagic events during the study period</measure>
    <time_frame>Jan 1,2015 - Dec 31st, 2019</time_frame>
    <description>Rates of hemorrhagic events during the study period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of DOAC prescribing for thrombosis prevention in hypercoagulable states</measure>
    <time_frame>Jan 1,2015 - Dec 31st, 2019</time_frame>
    <description>Rates of DOAC prescribing for thrombosis prevention in hypercoagulable states</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Hypercoagulable States</condition>
  <arm_group>
    <arm_group_label>Retrospective Cohort</arm_group_label>
    <description>All patients with hypercoagulable states identified by ICD-9/ICD-10 codes from January 1st, 2015 to December 31st, 2019</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Retrospective chart review</description>
    <arm_group_label>Retrospective Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hypercoagulable states identified by ICD-9/ICD-10 codes from January 1st,&#xD;
        2015 to December 31st, 2019&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients â‰¥ 18 year-old&#xD;
&#xD;
          -  Patients with diagnosis of hypercoagulable state identified by ICD-9/ICD-10 codes&#xD;
&#xD;
          -  Patients who were prescribed DOACs or VKA for primary or secondary prevention of&#xD;
             thrombosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with FDA-approved indications of oral anticoagulants including atrial&#xD;
             fibrillation or treatment/prevention of thrombotic events unrelated to specified&#xD;
             hypercoagulable states&#xD;
&#xD;
          -  Patients with incomplete electronic medical records&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Valerie Vuylsteke, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Methodist Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombophilia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

